• Clinical Communiqué Volume 5 Issue 2 June 2018

    Clinical Communiqué Volume 5 Issue 2 June 2018

    Welcome to the June 2018 edition of the Clinical Communiqué. In this edition, we present three cases of patients who died shortly after being assessed and discharged from an emergency department. In each case, an evolving abdominal problem was missed, and the symptoms were attributed to other, less critical causes.

  • Clinical Communiqué Volume 5 Issue 1 March 2018

    Clinical Communiqué Volume 5 Issue 1 March 2018

    Welcome to the first edition of the Clinical Communiqué for 2018. Before we look ahead for the year, it is worth recalling the June 2017 Clinical Communique. In that edition, we focussed on the complex issues surrounding the treatment of pain, and the risks associated with prescribing and combining sedative medications.

  • Clinical Communiqué Volume 5 Issue 3 September 2018

    Clinical Communiqué Volume 5 Issue 3 September 2018

    This edition is unapologetically different. Looking after our patients and improving the ways in which we keep them safe is only one side of the story. The other side is looking after ourselves. As healthcare professionals, our behaviour is not infallible and our health is not immune to the physical and mental illnesses that afflict those we treat. At times, we are all patients as well.

  • Clinical Communiqué Volume 4 Issue 4 December 2017

    Clinical Communiqué Volume 4 Issue 4 December 2017

    Welcome to the December 2017 edition of the Clinical Communiqué. For the final edition of the year, we have chosen to present a selection of cases that demonstrate some of the important non-clinical aspects of coronial investigations and inquest findings.

  • Background infusions with PCA can be unsafe – but are concurrent oral opioids any safer?

    Background infusions with PCA can be unsafe – but are concurrent oral opioids any safer?

    Following the discussion on patient-controlled-analgesia (PCA) in our June issue of the Clinical Communiqué, we present a supplementary expert commentary with pertinent clinical advice for our readers on the use of oral opioids with PCAs.

ARCHIVE